RT Journal Article
T1 Facial palsy after embolization with Squid® 12.
A1 Moreno-Paredes, Santiago
A1 Rodríguez-Alcalá, Laura
A1 Martín-Lagos Martínez, Juan
A1 Müller Locatelli, Nicolás
A1 Vázquez López, Cristina
A1 Vargas Fernández, José Luis
A1 Cabrera Peña, Álvaro
K1 Embolization
K1 Ethylene-vinyl alcohol copolymer
K1 Facial Palsy
K1 Neck paraganglioma
K1 Squid 12
AB Endovascular procedures with liquid embolic agents such as ethylene-vinyl alcohol (EVOH) copolymers are indicated before surgical treatment of cervical paraganglioma. Consequently, these agents are now available as low viscosity formulations, one of which is Squid 12, which are demonstrating superior vascular penetration. Cases of facial paralysis secondary to embolization of cervical vascular lesions with classic embolic agents have been reported in the English literature, however, this complication has not been described with new generation options such as Squid 12.We describe the case of a 43-year-old patient with a left neck carotid paraganglioma. Embolization was performed under general anaesthesia before surgical excision. In the immediate postoperative period, the patient developed total left facial palsy. Since the imaging tests (Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)) and neurological examination showed no involvement of additional cranial nerves (CN), we hypothesise that the main cause of this complication is ischemia of the vasa nervorum of CN VII secondary to embolization. Almost six months later, the patient continues to present total facial paralysis (Grade VI House-Brackmann facial paralysis scale), and palsy of the left CN X and XII as a complication secondary to surgical resection of the paraganglioma.This case is relevant since it is the first clinical case of permanent facial paralysis secondary to embolization with Squid 12.
YR 2021
FD 2021-01-30
LK http://hdl.handle.net/10668/17068
UL http://hdl.handle.net/10668/17068
LA en
DS RISalud
RD Apr 11, 2025